ESTA vs. EAR, ENOV, CDRE, AVNS, ZJYL, SMTI, INGN, LAKE, CLGN, and NTRB
Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Eargo (EAR), Enovis (ENOV), Cadre (CDRE), Avanos Medical (AVNS), Jin Medical International (ZJYL), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), CollPlant Biotechnologies (CLGN), and Nutriband (NTRB).
Establishment Labs (NASDAQ:ESTA) and Eargo (NASDAQ:EAR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking.
Establishment Labs has a net margin of -53.12% compared to Eargo's net margin of -263.14%. Eargo's return on equity of -135.08% beat Establishment Labs' return on equity.
In the previous week, Establishment Labs had 7 more articles in the media than Eargo. MarketBeat recorded 7 mentions for Establishment Labs and 0 mentions for Eargo. Establishment Labs' average media sentiment score of 1.11 beat Eargo's score of -0.10 indicating that Establishment Labs is being referred to more favorably in the media.
Establishment Labs has higher revenue and earnings than Eargo. Establishment Labs is trading at a lower price-to-earnings ratio than Eargo, indicating that it is currently the more affordable of the two stocks.
Establishment Labs received 99 more outperform votes than Eargo when rated by MarketBeat users. Likewise, 62.09% of users gave Establishment Labs an outperform vote while only 60.87% of users gave Eargo an outperform vote.
Establishment Labs presently has a consensus target price of $56.00, suggesting a potential upside of 16.38%. Given Establishment Labs' higher probable upside, analysts clearly believe Establishment Labs is more favorable than Eargo.
Establishment Labs has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Eargo has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500.
72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 80.5% of Eargo shares are held by institutional investors. 11.4% of Establishment Labs shares are held by insiders. Comparatively, 0.8% of Eargo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
Establishment Labs beats Eargo on 12 of the 17 factors compared between the two stocks.
Get Establishment Labs News Delivered to You Automatically
Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Establishment Labs Competitors List
Related Companies and Tools
